2023年5期
刊物介紹
本刊主要是及時(shí)報(bào)道我國(guó)在腫瘤防治研究領(lǐng)域包括癌癥基礎(chǔ)理論研究和癌癥預(yù)防、臨床治療研究方面的新進(jìn)展、新成果，內(nèi)容涉及腫瘤病因?qū)W與滸病學(xué)，實(shí)驗(yàn)?zāi)[瘤學(xué)、腫瘤細(xì)胞分子生物學(xué)，腫瘤病理學(xué)以及腫瘤影像診斷、腫瘤外科治療、化學(xué)治療、放射治療、介入治療、生物治療和中西醫(yī)結(jié)合治療腫瘤等各分支學(xué)科，旨在促進(jìn)國(guó)內(nèi)外學(xué)術(shù)交流，提高我國(guó)癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
Review Article
- Epidemiology of pancreatic cancer: New version,new vision
- MRD-directed and risk-adapted individualized stratified treatment of AML
- Inspired by novel radiopharmaceuticals: Rush hour of nuclear medicine
- Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy,safety,and biomarkers
Original Article
- Genetic susceptibility loci of lung cancer are associated with malignant risk of pulmonary nodules and improve malignancy diagnosis based on CEA levels
- A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer
- Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib
- Genetic abnormalities assist in pathological diagnosis and EBVpositive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients
- OpenNAU: An open-source platform for normalizing,analyzing,and visualizing cancer untargeted metabolomics data